STOCK TITAN
  1. Home
  2. Sec-filings
  3. CNS
  4. [Form 4] COHEN & STEERS, INC. Insider Trading Activity

CNS Form 4: Director Reena Aggarwal Reports 16,185 Shares After RSU Grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Reena Aggarwal, a director of Cohen & Steers, Inc. (CNS), reported a stock award transaction dated 10/01/2025. The filing shows acquisition of 423 shares of common stock resulting from restricted stock units granted by the issuer at a $0 per-share price, and the reporting person holds 16,185 shares following the transaction. The RSUs were 100% vested on the grant date, with the underlying shares to be delivered on the third anniversary of the grant date. The Form 4 was filed by one reporting person and signed on behalf of the reporting person by an attorney-in-fact on 10/03/2025.

Positive

  • 423 shares acquired via RSUs that were 100% vested on grant date
  • Total beneficial ownership reported at 16,185 shares, showing significant director holding

Negative

  • None.

Insights

Director received vested RSUs totaling 423 shares; delivery delayed until third anniversary.

The report documents a non-cash equity award: 423 common shares underlying restricted stock units were granted and are 100% vested on the grant date, indicating no further vesting condition. The award price is listed as $0, consistent with company compensation grants rather than open-market purchases.

Because the shares are payable on the third anniversary of the grant date, the reporting person does not yet hold these shares outright, though the award increases future potential dilution and aligns the director’s compensation with shareholder outcomes. The filing shows total beneficial ownership of 16,185 shares after the reported transaction.

Insider Aggarwal Reena
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 423 $0.00 --
Holdings After Transaction: Common Stock — 16,185 shares (Direct)
Footnotes (1)
  1. [object Object]
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Aggarwal Reena
(Last) (First) (Middle)
1166 AVENUE OF THE AMERICAS
(Street)
NEW YORK NY 10036
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
COHEN & STEERS, INC. [ CNS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/01/2025 A 423(1) A $0 16,185 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares of common stock underlying restricted stock units granted by the issuer to the reporting person. Such restricted stock units were 100% vested on the grant date and the related number of shares will be delivered to the reporting person on the third anniversary of the grant date.
Remarks:
/s/ Brian W. Heller, Attorney-in-Fact 10/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did the Form 4 filed for CNS disclose?

The Form 4 shows director Reena Aggarwal acquired 423 shares via restricted stock units on 10/01/2025, increasing her beneficial ownership to 16,185 shares.

Were the restricted stock units vested or subject to future vesting?

The filing states the RSUs were 100% vested on the grant date and the related shares will be delivered on the third anniversary of the grant.

What price was paid for the acquired shares reported on Form 4?

The transaction lists a per-share price of $0, indicating the shares derive from a compensation grant rather than an open-market purchase.

Who signed the Form 4 and when was it signed?

The Form 4 was signed on behalf of the reporting person by Brian W. Heller, Attorney-in-Fact on 10/03/2025.

Does the filing indicate multiple reporting persons filed the Form 4?

No. The form indicates it was filed by one reporting person.